MZL
Clinical trials for MZL explained in plain language.
Never miss a new study
Get alerted when new MZL trials appear
Sign up with your email to follow new studies for MZL, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New study aims to improve First-Line treatment for rare lymphoma
Disease control Not yet recruitingThis study looks at how well three different antibody-based drug combinations work as the first treatment for people with a rare type of blood cancer called marginal zone lymphoma (MZL). About 131 adults who have not yet been treated will receive one of three regimens based on th…
Matched conditions: MZL
Sponsor: Henan Cancer Hospital • Aim: Disease control
Last updated May 26, 2026 07:53 UTC
-
New pill shows promise for Hard-to-Treat lymphomas
Disease control Not yet recruitingThis study tests a daily pill called lisaftoclax (APG-2575) in 75 adults with slow-growing lymphomas (CLL, WM, or MZL) who cannot take or have stopped responding to standard treatments. The goal is to see if the drug is safe and can shrink or control the cancer. Participants take…
Matched conditions: MZL
Phase: PHASE2 • Sponsor: Henan Cancer Hospital • Aim: Disease control
Last updated May 19, 2026 11:47 UTC
-
New 'Living Drug' trial targets Tough-to-Treat blood cancers
Disease control Not yet recruitingThis early-stage study is testing a new type of CAR-T cell therapy, called BAFF-R CAR-T, for people with B-cell lymphomas that have come back or haven't responded to other treatments. Researchers will give the therapy at different doses to about 20 participants to check how safe …
Matched conditions: MZL
Phase: PHASE1, PHASE2 • Sponsor: Institute of Hematology & Blood Diseases Hospital, China • Aim: Disease control
Last updated Apr 06, 2026 14:05 UTC